Stay updated with breaking news from Jonp Connelly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers from University of Arizona Health Sciences are one step closer to solving one of the biggest barriers to regenerative medicine: immunological rejection by the recipient.
T cells are the key immune system component involved in killing cancer. Tumors produce signals that turn off these T cells, partially by forcing them to progressively differentiate (mature) into a hypofunctional state known as exhaustion.
/PRNewswire/ -- Scientists at St. Jude Children's Research Hospital identified a molecular mechanism that in a preclinical study unlocked the promise of CAR...
Scientists at St. Jude Children's Research Hospital identified proteins that help decide T cell fate and used the finding to improve CAR-T cell th...
/PRNewswire/ -- Scientists from St. Jude Children's Research Hospital have shown that the innate immune sensor, ZBP1, and its associated inflammatory cell...